Ann: Corporate Presentation, page-8

Bcal has been here before and just got whacked down with a wall of selling from Merchant Funds Management who still I estimate have about 14 million shares left to sell. They were sitting on the sell at 9 cents but now look to have ceased selling for now. See what happens.

I listened to the *** interview last week with Jayne Shaw. It was excellent and the most informative interview so far ( of which there have not been many ). Jayne gave some solid answers for the comparison to Inoviq blood test. All she would say was just ask the clinicians and doctors what they think ( says it all ). Merchant is a large shareholder in Inoviq also and have been plugging them as a buy but not Bcal. Go figure.